Site Map

About

 

• Corporate Overview

• Corporate History

• Executive Team

• Board of Directors

• Collaborations

• Business Development

 

 

Technology

 

• Momenta Advantage

• Case Study

• Complex Drug Characterization

• Publications

• Patents

 

 

Pipeline

 

• Pipeline

• Complex Generics

• Enoxaparin Sodium Injection

• M356

• Biosimilars

• Strategy

• Development Program

• Novel Products

• M402

• Sialylation Technology

 

 

Investors

 

• Overview

• Stock Information

• Financial Information

• Press Releases

• Events & Presentations

• Corporate Governance

• Investor FAQs

• Email & News Alerts

• Contact Us

 

 

Careers

 

• Career Center

• The Momenta Experience

• Corporate Values and Commitment to our Community

• Employee Benefits at Momenta

• Search Current Openings

 

 

Last revised 3/26/2013